Closed pnrobinson closed 5 years ago
https://www.ncbi.nlm.nih.gov/books/NBK1322/
The activities of the carboxylases in fibroblasts of individuals with holocarboxylase synthetase deficiency become near-normal to normal when cultured in medium supplemented with biotin (high biotin).
We had the cost listed as too low so this was included even though the list I sent wasn't intended at this stage to include lab tests.
@MickeySegal Would you agree with this label? Otherwise the label does not really match what is happening, I think. Positive carboxylase test response to biotin supplementation or perhaps even better Positive holocarboxylase synthetase response to biotin supplementation
@MickeySegal any update on this?
We use "Positive holocarboxylase synthetase response to biotin supplementation".
If you are assigning an HPO term we will use it, but we have a list of a few thousand lab terms we could provide but were holding that for another stage and had included this with our clinical list because we had erroneously listed the cost as one for a clinical finding.
@MickeySegal -- OK. I think we would love to add more lab tests to HPO in the future. Perhaps it is best to close this issue for now, and then to systematically go through the lab tests. Perhaps this approach is also interesting for your software (https://github.com/data2health/ehr2HPO.prj) and if you do see any areas of synergy we should talk. I will close this item for now.
@MickeySegal -- can you provide background/definition?